Increased Revenue and Growth
Revenue from continuing operations was $13 million, an increase of 14% over the prior year period. Growth was driven by strong device sales, with mass spec devices accounting for 60% of revenue.
Record Device Placements
The company placed 164 devices, including a record number of XplorIR units, marking the highest quarterly performance for XplorIR.
Launch of VipIR Product
Successfully launched VipIR, a new 3-in-1 handheld chemical analyzer, aimed at global customs organizations, combining FTIR and Raman spectroscopy.
Legislative Support and Funding
Recent U.S. legislative actions, including the U.S. budget FY '26 reconciliation bill, provide approximately $1.7 billion in grant funding, representing an 11% increase from 2024 levels.
Operational Efficiency Improvements
Completed transfer of MX908 manufacturing to a lower-cost facility in Danbury, Connecticut, and completed the relocation of the corporate office to a smaller site in Burlington, Massachusetts.